Modification of Multidrug Resistance by Magnetic Exposure Indicated from the Point of View of Nuclear Medicine
Project/Area Number |
09670954
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Radiation science
|
Research Institution | Keio University |
Principal Investigator |
NAKAMURA Kayoko Keio University School of Medicine; Radiology; Assistant Professor, 医学部, 専任講師 (20124480)
|
Project Period (FY) |
1997 – 1998
|
Project Status |
Completed (Fiscal Year 1998)
|
Budget Amount *help |
¥3,100,000 (Direct Cost: ¥3,100,000)
Fiscal Year 1998: ¥1,100,000 (Direct Cost: ¥1,100,000)
Fiscal Year 1997: ¥2,000,000 (Direct Cost: ¥2,000,000)
|
Keywords | Magnetic Exposure / Tumor / Chemosensitivity / Multidrug Resistance / Tc-99m-MIBI / P-glycoprotein / 抗がん剤 / P-糖たん白質 / P糖蛋白質 |
Research Abstract |
The effects of magnetic field on the chemosensitivity of tumor cells were investigated by using Tc-99m-MIBI uptake; which indicates the function of P-glycoprotein. The cells lines studies were anaplastic thyroid cancer cell lines established from patients; human epidermoid cell KB-31; KB-31 transfected with mdr gene KB-G2; and MRP-cell line CA-500. By the strong magnetic exposure for a short period (one hour) the Tc-99m-MIBI uptake in some tumor cells (not all cells) was reduced. Under weak magnetic field the Tc-99m-MIBI uptake was increased in all tumor cells studied. These effects were not altered in the presence of anti-P-glycoprotein antibody or verapamil that inhibits the function of P-glycoprotein. It can be, therefore, concluded that the magnetic effects were different from cell to cell, and that these effects were not specific for P-glycoprotein. Magnetic exposure may be one of modifications that reverse multidrug resistance of tumor cells. Tc-99m-MIBI uptake in cells is a good indicator to assess the multidrug resistance modification.
|
Report
(3 results)
Research Products
(30 results)